Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Elizabethtown › NPI 1689282147
Hospital

Baptist Healthcare System INC

Baptist Healthcare System INC was paid $95.61M by Medicaid between Sep 2020 and Dec 2024, across 539 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.

33Billing provider infoBAPTIST HEALTHCARE SYSTEM INC
ELIZABETHTOWN, KY 42701
33aNPI1689282147assigned 07/21/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$95.61M
24GClaims1,819,634
24DCodes billed539
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#7 of 36
Median peer was paid$36.08M
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020547$10.89
2021431,649$23.27M
2022472,267$23.93M
2023506,179$24.76M
2024incomplete408,992$23.64M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 51,617 43,707 $12.11M
74177 Computed tomography, abdomen and pelvis; with contrast material 7.8% 11,752 10,346 $7.45M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.4% 21,484 17,719 $6.14M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.3% 8,860 7,301 $3.18M
70450 Computed tomography, head or brain; without contrast material 2.3% 7,455 6,150 $2.19M
74176 Computed tomography, abdomen and pelvis; without contrast material 2.0% 3,529 3,115 $1.95M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.0% 4,173 2,962 $1.93M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.9% 3,421 1,419 $1.85M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 11,335 10,146 $1.61M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.6% 38,217 20,531 $1.49M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 11,565 5,514 $1.41M
96375 Therapeutic injection; each additional sequential IV push 1.5% 20,243 15,181 $1.41M
527 more codes
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 2,507 $1.34M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.4% 1,112 $1.30M
41899 Unlisted procedure, dentoalveolar structures 1.4% 537 $1.30M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.3% 2,622 $1.20M
71260 Computed tomography, thorax, diagnostic; with contrast material 1.2% 3,746 $1.18M
80053 Comprehensive metabolic panel 1.2% 121,801 $1.17M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 24,305 $1.09M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.1% 1,896 $1.05M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.1% 16,842 $1.05M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.0% 2,217 $993K
71045 Radiologic examination, chest; single view <1% 23,299 $951K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,403 $917K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 19,994 $914K
G0378 Hospital observation service, per hour <1% 1,637 $834K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,947 $832K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,655 $806K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,167 $786K
36415 Collection of venous blood by venipuncture <1% 165,355 $748K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,186 $727K
74178 <1% 773 $717K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 11,358 $709K
59025 Fetal non-stress test <1% 5,099 $668K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,212 $627K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 96,567 $615K
71250 <1% 3,111 $566K
J2785 Injection, regadenoson, 0.1 mg <1% 784 $529K
73221 <1% 1,273 $494K
93017 <1% 1,440 $475K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,743 $475K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 453 $458K
84443 Thyroid stimulating hormone (TSH) <1% 33,541 $451K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,006 $446K
72141 <1% 1,163 $437K
72125 Computed tomography, cervical spine; without contrast material <1% 1,465 $435K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,222 $425K
78815 Positron emission tomography (PET) for limited area imaging <1% 674 $421K
76830 Ultrasound, transvaginal <1% 3,364 $412K
73562 <1% 3,314 $390K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 19,687 $381K
96361 Intravenous infusion, hydration; each additional hour <1% 6,543 $378K
80061 Lipid panel <1% 33,250 $377K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 8,954 $366K
83880 <1% 11,230 $362K
93971 <1% 1,582 $361K
73630 <1% 2,760 $358K
72100 <1% 3,312 $349K
73030 <1% 3,376 $348K
71046 Radiologic examination, chest; 2 views <1% 7,746 $342K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 10,899 $325K
74018 <1% 3,391 $325K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 6,275 $319K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 10,823 $312K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 13,055 $311K
73130 <1% 2,358 $303K
73610 <1% 2,437 $298K
76642 <1% 2,344 $296K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 20,433 $294K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,152 $282K
76775 <1% 1,217 $276K
70486 <1% 849 $269K
72110 <1% 1,320 $261K
96376 <1% 3,858 $246K
72050 <1% 1,527 $239K
73110 <1% 1,718 $229K
84702 <1% 17,717 $219K
76536 <1% 1,799 $219K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,524 $218K
80050 General health panel <1% 6,304 $215K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,585 $204K
J3490 Unclassified drugs <1% 2,088 $203K
96367 <1% 2,187 $202K
47562 <1% 144 $200K
94060 <1% 1,601 $199K
84484 <1% 18,883 $198K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,893 $194K
C1769 Guide wire <1% 1,528 $194K
72072 <1% 1,421 $191K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,702 $189K
71275 Computed tomographic angiography, chest, with contrast material <1% 320 $188K
C1776 Joint device (implantable) <1% 124 $188K
87480 <1% 9,006 $174K
77066 Tomosynthesis, mammo <1% 1,662 $170K
73502 <1% 2,116 $168K
74022 <1% 938 $167K
70491 <1% 473 $162K
83036 Hemoglobin; glycosylated (A1C) <1% 21,884 $157K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,676 $157K
C1889 Implantable/insertable device, not otherwise classified <1% 1,473 $150K
74183 <1% 364 $146K
87086 Culture, bacterial; quantitative colony count, urine <1% 19,712 $145K
84439 <1% 19,020 $144K
87660 <1% 8,500 $143K
87510 <1% 8,501 $141K
82607 <1% 11,476 $141K
83690 <1% 24,721 $140K
47563 <1% 196 $138K
71271 <1% 1,637 $131K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 805 $131K
95806 <1% 650 $129K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,030 $128K
95886 <1% 316 $127K
78264 <1% 237 $126K
87506 <1% 609 $125K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 145 $124K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 8,715 $120K
74019 <1% 1,219 $118K
87081 <1% 18,023 $117K
86803 <1% 9,665 $115K
72040 <1% 826 $114K
77065 Tomosynthesis, mammo <1% 1,381 $113K
84466 <1% 10,988 $113K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 3,085 $112K
58661 <1% 113 $109K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,543 $105K
82746 <1% 8,719 $102K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,795 $101K
93880 <1% 521 $101K
78227 <1% 174 $98K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 5,410 $98K
82728 <1% 8,492 $96K
83735 <1% 16,986 $96K
80074 <1% 2,950 $95K
C1781 Mesh (implantable) <1% 124 $95K
95816 <1% 235 $94K
73590 <1% 838 $94K
71101 <1% 773 $93K
J7050 Infusion, normal saline solution, 250 cc <1% 3,813 $93K
73560 <1% 929 $93K
97161 <1% 3,066 $92K
76870 <1% 795 $91K
73090 <1% 798 $91K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 979 $90K
77080 <1% 1,615 $88K
88304 <1% 2,450 $86K
J2704 Injection, propofol, 10 mg <1% 17,222 $83K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 7,348 $81K
82077 <1% 6,091 $81K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 984 $80K
94726 <1% 1,329 $79K
70498 <1% 280 $79K
70496 <1% 236 $79K
88307 <1% 841 $78K
73080 <1% 763 $77K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 872 $76K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,272 $76K
12001 <1% 621 $75K
96415 <1% 332 $72K
88142 <1% 3,906 $72K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening <1% 4,747 $70K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 28 $67K
81001 <1% 24,181 $66K
86003 <1% 1,130 $65K
80143 <1% 4,116 $65K
80048 Basic metabolic panel (calcium, ionized) <1% 8,932 $64K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 150 $62K
94729 <1% 1,204 $62K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 56 $62K
83540 <1% 11,649 $62K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 158 $61K
80179 <1% 4,083 $59K
83605 <1% 6,187 $57K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,905 $56K
77063 Screening digital breast tomosynthesis, bilateral <1% 6,820 $53K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 827 $53K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,960 $52K
87040 <1% 6,094 $52K
82948 <1% 8,158 $52K
82805 <1% 879 $52K
97535 Self-care/home management training, each 15 minutes <1% 1,614 $51K
10060 <1% 153 $51K
88342 <1% 1,088 $50K
85027 <1% 9,172 $50K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 380 $49K
87186 <1% 6,782 $49K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 691 $47K
87522 Neg quan hep c or qual rna <1% 1,411 $47K
77336 <1% 430 $42K
84403 <1% 2,017 $42K
64447 <1% 30 $41K
87070 <1% 5,748 $40K
95811 <1% 29 $40K
36591 <1% 1,833 $40K
83013 <1% 689 $38K
76801 <1% 363 $38K
87077 <1% 5,451 $38K
97165 <1% 1,011 $38K
76000 <1% 385 $37K
80055 <1% 706 $37K
J1170 Injection, hydromorphone, up to 4 mg <1% 8,802 $37K
86850 <1% 4,031 $35K
91200 <1% 330 $35K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 190 $34K
73140 <1% 394 $34K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 2,258 $33K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,377 $32K
C1726 Catheter, balloon dilatation, non-vascular <1% 165 $32K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,749 $32K
82962 <1% 8,326 $32K
85610 <1% 8,877 $32K
76770 <1% 165 $31K
76942 <1% 274 $31K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,569 $31K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 587 $30K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 137 $30K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 273 $30K
81003 <1% 14,477 $30K
86038 <1% 2,893 $29K
C2617 Stent, non-coronary, temporary, without delivery system <1% 444 $29K
82784 <1% 1,865 $29K
84112 <1% 355 $29K
84146 <1% 1,770 $28K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 85 $28K
83970 <1% 893 $28K
82043 <1% 5,788 $28K
C9776 Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure) <1% 32 $27K
87147 <1% 3,088 $27K
0001A <1% 890 $27K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 21,239 $26K
90715 <1% 779 $26K
0002A <1% 811 $25K
82550 <1% 4,471 $25K
87807 <1% 2,242 $25K
81025 <1% 3,934 $25K
36430 <1% 49 $25K
83001 <1% 1,604 $25K
82570 <1% 5,773 $25K
87653 <1% 761 $25K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 738 $24K
12011 <1% 213 $24K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 69 $24K
84402 <1% 1,141 $24K
87493 <1% 1,170 $24K
86480 <1% 459 $24K
87088 <1% 3,604 $23K
82274 <1% 1,717 $23K
84481 <1% 1,644 $22K
82553 <1% 2,533 $22K
87505 <1% 230 $21K
87340 <1% 2,520 $21K
86696 <1% 1,325 $21K
12002 <1% 153 $21K
87800 <1% 615 $20K
86780 <1% 1,815 $20K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 154 $20K
86140 <1% 4,462 $19K
95911 <1% 34 $19K
74420 <1% 42 $19K
86665 <1% 696 $18K
86235 <1% 251 $18K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 883 $18K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,288 $17K
83002 <1% 1,151 $17K
86225 <1% 1,566 $17K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,520 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 326 $16K
85379 <1% 1,929 $16K
85730 <1% 3,636 $16K
86677 <1% 684 $16K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,707 $16K
72146 <1% 40 $15K
86695 <1% 1,224 $15K
78226 <1% 37 $15K
64721 <1% 36 $15K
86376 <1% 1,254 $14K
76999 <1% 195 $14K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 211 $14K
96417 <1% 118 $14K
82785 <1% 926 $14K
84703 <1% 2,211 $13K
86901 <1% 4,461 $13K
86900 <1% 4,315 $13K
J1756 Injection, iron sucrose, 1 mg <1% 137 $13K
C1758 Catheter, ureteral <1% 367 $12K
99152 <1% 174 $12K
84100 <1% 3,121 $12K
87205 <1% 3,272 $12K
86618 <1% 698 $11K
80081 <1% 132 $11K
83020 <1% 978 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 22,915 $11K
36600 <1% 328 $11K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 9,604 $11K
86592 <1% 2,450 $11K
84153 <1% 697 $10K
85652 <1% 4,469 $10K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 76 $10K
86757 <1% 307 $10K
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 1,520 $10K
80076 <1% 1,334 $10K
86334 <1% 507 $9K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,778 $9K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 99 $9K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,063 $9K
82103 <1% 745 $9K
93798 <1% 332 $9K
86431 <1% 1,809 $9K
83655 <1% 774 $9K
82565 <1% 881 $9K
82105 <1% 582 $9K
84156 <1% 2,765 $9K
86200 <1% 760 $8K
82627 <1% 438 $8K
83630 <1% 485 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 560 $8K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,480 $8K
96523 <1% 307 $8K
82950 <1% 1,724 $8K
86381 <1% 415 $8K
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 706 $8K
82150 <1% 1,422 $8K
99153 Mod sedat endo service >5yrs <1% 57 $8K
94010 <1% 112 $8K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 117 $8K
73552 <1% 72 $8K
80069 <1% 1,024 $8K
83525 <1% 835 $8K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 2,242 $8K
64415 <1% 16 $8K
84550 <1% 1,971 $8K
86364 <1% 600 $7K
94761 <1% 567 $7K
84436 <1% 1,304 $7K
49083 <1% 25 $7K
74230 <1% 67 $7K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 174 $7K
86762 <1% 532 $7K
77002 <1% 37 $7K
86664 <1% 510 $7K
0012A <1% 269 $6K
86800 <1% 513 $6K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 19 $6K
93923 <1% 71 $6K
82670 <1% 268 $6K
88302 <1% 402 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,555 $6K
82947 <1% 1,653 $6K
88300 <1% 403 $6K
82375 <1% 488 $6K
83516 <1% 550 $6K
31624 <1% 28 $6K
43249 <1% 52 $6K
81002 <1% 1,162 $6K
J1790 Injection, droperidol, up to 5 mg <1% 817 $6K
J1453 Injection, fosaprepitant, 1 mg <1% 117 $6K
72114 <1% 28 $5K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 690 $5K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 279 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 9,181 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 278 $5K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 118 $5K
93225 <1% 63 $5K
84144 <1% 303 $5K
88312 <1% 118 $5K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,182 $5K
88341 <1% 43 $5K
93970 <1% 34 $5K
87071 <1% 661 $5K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 395 $5K
82803 <1% 204 $5K
84145 <1% 229 $5K
29580 <1% 59 $4K
73070 <1% 32 $4K
J1644 Injection, heparin sodium, per 1000 units <1% 1,696 $4K
95909 <1% 12 $4K
86706 <1% 525 $4K
72158 <1% 19 $4K
73060 <1% 72 $4K
97116 <1% 274 $4K
0011A <1% 243 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,349 $4K
84479 <1% 826 $4K
82140 <1% 320 $4K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 4,245 $4K
86008 <1% 382 $4K
86015 <1% 391 $4K
86256 <1% 179 $4K
86704 <1% 381 $4K
A4648 Tissue marker, implantable, any type, each <1% 85 $4K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 480 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,160 $3K
95819 <1% 37 $3K
86308 <1% 761 $3K
G0148 Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening <1% 136 $3K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 1,964 $3K
97802 <1% 250 $3K
82533 <1% 226 $3K
85014 <1% 735 $3K
82672 <1% 169 $3K
82390 <1% 350 $3K
82248 <1% 826 $3K
88108 <1% 133 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 687 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,265 $3K
86701 <1% 384 $3K
31500 <1% 29 $3K
87902 <1% 14 $3K
83050 <1% 389 $3K
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg <1% 112 $3K
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 607 $3K
87529 <1% 43 $3K
92523 <1% 27 $3K
86923 <1% 56 $3K
J2060 Injection, lorazepam, 2 mg <1% 1,769 $3K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,808 $3K
94618 <1% 54 $3K
82009 <1% 669 $2K
93325 <1% 13 $2K
J2469 Injection, palonosetron hcl, 25 mcg <1% 334 $2K
86231 <1% 247 $2K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 402 $2K
83498 <1% 98 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 153 $2K
82652 <1% 83 $2K
92609 <1% 32 $2K
97022 <1% 377 $2K
84165 <1% 201 $2K
86666 <1% 62 $2K
83615 <1% 307 $2K
80164 <1% 159 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 544 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 340 $2K
73523 <1% 16 $2K
J3370 Injection, vancomycin hcl, 500 mg <1% 198 $2K
70360 <1% 14 $2K
J1956 Injection, levofloxacin, 250 mg <1% 662 $1K
82820 <1% 162 $1K
86258 <1% 117 $1K
82977 <1% 233 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 108 $1K
87899 <1% 248 $1K
73620 <1% 16 $1K
82951 <1% 123 $1K
83921 <1% 64 $1K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 466 $1K
92610 <1% 15 $1K
94664 <1% 46 $1K
85018 <1% 437 $1K
82365 <1% 79 $1K
86769 <1% 60 $1K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 111 $1K
J1940 Injection, furosemide, up to 20 mg <1% 298 $969.49
85045 <1% 281 $914.43
87449 <1% 126 $908.08
84460 <1% 187 $906.79
87484 <1% 27 $871.66
J3480 Injection, potassium chloride, per 2 meq <1% 86 $834.84
64450 <1% 16 $828.93
87045 <1% 111 $812.25
87593 <1% 12 $796.07
0004A <1% 22 $784.48
87116 <1% 88 $766.80
88173 <1% 23 $750.76
J1171 Injection, hydromorphone, 0.1 mg <1% 192 $739.90
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 144 $724.67
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 512 $724.53
86060 <1% 130 $722.56
86694 <1% 58 $718.54
87046 <1% 111 $714.10
97162 <1% 13 $710.06
85007 <1% 279 $682.99
97014 <1% 41 $666.16
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 37 $656.90
82247 <1% 192 $655.40
86663 <1% 48 $640.20
J3411 Injection, thiamine hcl, 100 mg <1% 120 $613.17
97010 <1% 373 $610.83
83883 <1% 31 $610.18
86141 <1% 73 $603.49
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 725 $595.24
80178 <1% 100 $588.36
82330 <1% 53 $587.96
0031A <1% 24 $567.04
84410 <1% 13 $564.08
84480 <1% 66 $558.68
87350 <1% 74 $552.29
G0475 Hiv antigen/antibody, combination assay, screening <1% 25 $545.48
82175 <1% 20 $541.46
84450 <1% 115 $535.15
86707 <1% 70 $531.06
82040 <1% 42 $515.26
86255 <1% 66 $482.00
82378 <1% 33 $474.00
86705 <1% 69 $457.85
83014 <1% 82 $433.11
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 26 $416.68
94760 <1% 57 $409.60
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 116 $384.24
82104 <1% 28 $349.50
87102 <1% 46 $344.81
J1596 Injection, glycopyrrolate, 0.1 mg <1% 316 $338.50
86403 <1% 34 $337.52
97012 <1% 46 $336.12
86063 <1% 87 $326.07
87338 <1% 28 $317.58
82525 <1% 28 $297.84
82952 <1% 93 $288.89
82397 <1% 13 $280.29
84681 <1% 13 $270.53
83721 <1% 87 $260.48
89051 <1% 56 $257.60
86160 <1% 12 $256.08
36416 <1% 63 $221.30
83993 <1% 12 $217.98
J1953 Injection, levetiracetam, 10 mg <1% 29 $215.50
87206 <1% 51 $204.82
86645 <1% 12 $199.67
84520 <1% 54 $196.09
86644 <1% 12 $170.52
87328 <1% 19 $164.46
82310 <1% 19 $159.51
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 72 $157.36
83010 <1% 12 $149.07
87329 <1% 19 $142.56
C9113 Injection, pantoprazole sodium, per vial <1% 53 $140.05
83527 <1% 12 $129.50
J0736 Injection, clindamycin phosphate, 300 mg <1% 19 $106.19
J1630 Injection, haloperidol, up to 5 mg <1% 68 $101.92
86593 <1% 26 $96.80
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 88 $87.51
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 14 $77.56
J0592 Injection, buprenorphine hydrochloride, 0.1 mg <1% 12 $70.11
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 199 $65.70
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 30 $63.60
81050 <1% 13 $50.99
J0456 Injection, azithromycin, 500 mg <1% 12 $30.15
84155 <1% 13 $29.36
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 86 $16.28

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARRICO, RICHARD (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under CARRICO, RICHARD

Full network →
ProviderLocationPaid
Baptist Healthcare System, INCCorbin, KY$121.50M
Baptist Healthcare System, INCLexington, KY$98.07M
Baptist Health Deaconess Madisonville INCMadisonville, KY$80.89M
Baptist Healthcare System, INCPaducah, KY$72.57M
Baptist Healthcare System INC.Louisville, KY$62.41M
Baptist Healthcare System, INC.Richmond, KY$58.51M
Baptist Healthcare System, INC.New Albany, IN$34.67M
Baptist Healthcare System, INC.La Grange, KY$16.01M
Baptist Health Surgery Center LLCLexington, KY$2.90M
Baptist Healthcare System, INC.Louisville, KY$1.34M
Baptist Healthcare System, INC.Lexington, KY$1.08M
Baptist Health Deaconess Madisonville INCMadisonville, KY$834K
Baptist Healthcare System, INC.Louisville, KY$184K
Baptist Healthcare System INCCorbin, KY$142K
Baptist Healthcare System INCNew Albany, IN$97K
Baptist Health Deaconess Madisonville INCMadisonville, KY$94K
Baptist Healthcare System INCElizabethtown, KY$54K
Baptist Healthcare System INCLouisville, KY$47K
Baptist Healthcare System INCLexington, KY$43K
Baptist Healthcare System, INC.Lexington, KY$10K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.